Insights from Deal Trends: Betting on Tumor Immunology

In this podcast from the 2019 Immuno-Oncology 360° conference, Cello Health BioConsulting's EVP, Oncology Practice Head, Dr Jeff Bockman discusses deal-making and investments in the I-O space to see what can be learned about the expanding and shifting landscape of BioPharma and investor interest by examining who is placing what kinds of bets on which targets and modalities, at what stage and with what terms.

Additional topics include:

• Where are the next big paradigm shifts going to be?
• Where is the next great target that will supersize foundational checkpoint therapy?

Join us for the 6th annual IO360° conference on February 26-28, 2020 at the Crowne Plaza Times Square hotel in New York City.

To learn more about the event, please visit IO360 2020.